Variant report
Variant | rs10411264 |
---|---|
Chromosome Location | chr19:41394336-41394337 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | USF1 | chr19:41394085-41394455 | K562 | blood: | n/a | n/a |
2 | ZNF384 | chr19:41394098-41394370 | K562 | blood: | n/a | n/a |
3 | MAFK | chr19:41394224-41394447 | K562 | blood: | n/a | n/a |
4 | MAFF | chr19:41394255-41394444 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CYP2G1P | TF binding region |
rs_ID | r2[population] |
---|---|
rs10406188 | 1.00[AFR][1000 genomes];0.99[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10410750 | 0.92[ASN][1000 genomes] |
rs10411877 | 0.83[ASN][1000 genomes] |
rs10414481 | 0.95[AFR][1000 genomes];0.99[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10416968 | 0.93[ASN][1000 genomes] |
rs10418318 | 0.98[ASN][1000 genomes] |
rs10419393 | 0.91[CHB][hapmap];0.81[GIH][hapmap];1.00[JPT][hapmap];0.94[ASN][1000 genomes] |
rs10421888 | 0.97[ASN][1000 genomes] |
rs10423165 | 0.82[AMR][1000 genomes];0.92[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs10424691 | 0.81[ASN][1000 genomes] |
rs10424834 | 0.85[ASN][1000 genomes] |
rs10425176 | 0.95[CHB][hapmap];0.88[JPT][hapmap] |
rs11083577 | 0.87[ASN][1000 genomes] |
rs11083580 | 0.90[ASN][1000 genomes] |
rs11083582 | 0.98[ASN][1000 genomes] |
rs11665969 | 0.97[ASN][1000 genomes] |
rs11669113 | 0.81[ASN][1000 genomes] |
rs12973598 | 0.86[CHB][hapmap];0.90[JPT][hapmap];0.85[ASN][1000 genomes] |
rs12975382 | 0.85[ASN][1000 genomes] |
rs12982395 | 0.93[ASN][1000 genomes] |
rs2316213 | 0.95[CHB][hapmap];0.90[JPT][hapmap] |
rs2316215 | 0.84[ASN][1000 genomes] |
rs2644904 | 0.90[ASN][1000 genomes] |
rs28427254 | 0.81[ASN][1000 genomes] |
rs28472879 | 0.99[AFR][1000 genomes];0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs28503746 | 0.96[ASN][1000 genomes] |
rs28619553 | 0.93[ASN][1000 genomes] |
rs2935235 | 0.92[ASN][1000 genomes] |
rs3797218 | 0.93[ASN][1000 genomes] |
rs3815714 | 0.90[ASN][1000 genomes] |
rs3852870 | 0.95[CHB][hapmap];1.00[CHD][hapmap];0.86[GIH][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes] |
rs3865457 | 0.84[JPT][hapmap];0.93[AFR][1000 genomes];0.92[AMR][1000 genomes];0.95[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3869579 | 0.95[CHB][hapmap];0.95[CHD][hapmap];0.81[GIH][hapmap];1.00[JPT][hapmap];0.92[ASN][1000 genomes] |
rs3875159 | 0.95[CHB][hapmap];0.98[CHD][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap] |
rs3909341 | 0.97[ASN][1000 genomes] |
rs3909342 | 0.98[ASN][1000 genomes] |
rs4105141 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.98[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs4105142 | 0.97[ASN][1000 genomes] |
rs4105143 | 0.95[ASN][1000 genomes] |
rs4142867 | 0.93[ASN][1000 genomes] |
rs4802095 | 0.86[CHB][hapmap];0.80[JPT][hapmap];0.89[ASN][1000 genomes] |
rs4803389 | 0.93[ASN][1000 genomes] |
rs4803390 | 0.89[ASN][1000 genomes] |
rs4803391 | 0.92[ASN][1000 genomes] |
rs4803393 | 0.87[CHB][hapmap];1.00[JPT][hapmap] |
rs4803400 | 0.91[CHB][hapmap];1.00[CHD][hapmap];0.86[GIH][hapmap];1.00[JPT][hapmap];0.94[ASN][1000 genomes] |
rs5007415 | 1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56081734 | 0.93[ASN][1000 genomes] |
rs61482096 | 0.87[ASN][1000 genomes] |
rs6508953 | 0.82[CHB][hapmap];0.81[CHD][hapmap];1.00[JPT][hapmap];0.89[ASN][1000 genomes] |
rs67421541 | 0.98[ASN][1000 genomes] |
rs7252852 | 0.91[CHB][hapmap];1.00[CHD][hapmap];0.83[GIH][hapmap];1.00[JPT][hapmap];0.94[ASN][1000 genomes] |
rs7254188 | 0.92[AFR][1000 genomes];0.86[AMR][1000 genomes];0.93[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs7258590 | 0.84[ASN][1000 genomes] |
rs7258728 | 0.88[ASN][1000 genomes] |
rs7343061 | 0.92[ASN][1000 genomes] |
rs8103288 | 0.98[AFR][1000 genomes];0.99[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv2758500 | chr19:41291627-41546068 | Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Strong transcription Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 36 gene(s) | inside rSNPs | diseases |
2 | esv2758762 | chr19:41291627-41546068 | Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 36 gene(s) | inside rSNPs | diseases |
3 | nsv1066637 | chr19:41309211-41597896 | Weak transcription Enhancers Genic enhancers Active TSS Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 29 gene(s) | inside rSNPs | diseases |
4 | esv2760509 | chr19:41325004-41394336 | Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers Strong transcription ZNF genes & repeats Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 12 gene(s) | inside rSNPs | diseases |
5 | nsv1056244 | chr19:41329218-41397661 | Enhancers Active TSS Weak transcription Flanking Active TSS Strong transcription Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
6 | esv1827726 | chr19:41329872-41395056 | Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
7 | esv1832156 | chr19:41332004-41399077 | Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Enhancers Strong transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
8 | nsv9729 | chr19:41337805-41394407 | Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 7 gene(s) | inside rSNPs | diseases |
9 | nsv1065886 | chr19:41339857-41397661 | Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 7 gene(s) | inside rSNPs | diseases |
10 | esv33053 | chr19:41340629-41400635 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 7 gene(s) | inside rSNPs | diseases |
11 | esv1827139 | chr19:41348820-41395889 | Enhancers Strong transcription Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive region | 6 gene(s) | inside rSNPs | diseases |
12 | nsv1056284 | chr19:41360131-41399887 | Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | inside rSNPs | diseases |
13 | nsv1055263 | chr19:41360358-41397661 | Enhancers Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | inside rSNPs | diseases |
14 | esv3337314 | chr19:41388910-41534583 | ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs10411264 | CYP2G1P | cis | lung | GTEx |
rs10411264 | HSD17B14 | cis | cerebellum | SCAN |
rs10411264 | SLC17A7 | cis | parietal | SCAN |
rs10411264 | KPTN | cis | parietal | SCAN |
rs10411264 | CABP5 | cis | cerebellum | SCAN |
rs10411264 | RELB | cis | parietal | SCAN |
rs10411264 | ZNF541 | cis | cerebellum | SCAN |
rs10411264 | PTH2 | cis | parietal | SCAN |
rs10411264 | NANOS2 | cis | parietal | SCAN |
rs10411264 | APOC4 | cis | cerebellum | SCAN |
rs10411264 | PRKD2 | cis | parietal | SCAN |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:41392800-41394400 | Enhancers | A549 | lung |
2 | chr19:41393200-41397600 | Weak transcription | Ovary | ovary |
3 | chr19:41394000-41395200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr19:41394200-41394600 | Enhancers | Adipose Nuclei | Adipose |